Immunotherapy throughout the decades: From Noon to now

Ira Finegold, Robert J. Dockhorn, Daniel Ein, William K. Dolen, John Oppenheimer, Lawrence H. Potter

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Objective To review major milestones in the development of subcutaneous allergen immunotherapy in 20-year segments. Data Sources Review of the literature available in textbooks and journals. Study Selection Articles and books addressing major achievements in the development of subcutaneous allergy immunotherapy were selected for inclusion in this review. Results Immunotherapy administration has improved the lives of possibly millions of patients with hay fever. Asthmatic symptoms have been relieved if not ablated in millions as well. Insect venom hypersensitivity became treatable and highly effective. In the beginning years of immunotherapy, it was clear that immunotherapy worked; in the later years, the mechanisms for this efficacy were discovered. In this case, the therapy preceded its validation. Methods, materials, and safety have vastly improved. Postulated mechanisms explain much but not everything. Conclusions There is still research to be accomplished, improvements to be made, and, of course, patients to be made well.

Original languageEnglish (US)
Pages (from-to)328-336
Number of pages9
JournalAnnals of Allergy, Asthma and Immunology
Volume105
Issue number5
DOIs
StatePublished - Nov 1 2010

Fingerprint

Immunotherapy
Book Selection
Hypersensitivity
Immunologic Desensitization
Seasonal Allergic Rhinitis
Textbooks
Information Storage and Retrieval
Venoms
Insects
Safety
Research
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Finegold, I., Dockhorn, R. J., Ein, D., Dolen, W. K., Oppenheimer, J., & Potter, L. H. (2010). Immunotherapy throughout the decades: From Noon to now. Annals of Allergy, Asthma and Immunology, 105(5), 328-336. https://doi.org/10.1016/j.anai.2010.08.008

Immunotherapy throughout the decades : From Noon to now. / Finegold, Ira; Dockhorn, Robert J.; Ein, Daniel; Dolen, William K.; Oppenheimer, John; Potter, Lawrence H.

In: Annals of Allergy, Asthma and Immunology, Vol. 105, No. 5, 01.11.2010, p. 328-336.

Research output: Contribution to journalReview article

Finegold, I, Dockhorn, RJ, Ein, D, Dolen, WK, Oppenheimer, J & Potter, LH 2010, 'Immunotherapy throughout the decades: From Noon to now', Annals of Allergy, Asthma and Immunology, vol. 105, no. 5, pp. 328-336. https://doi.org/10.1016/j.anai.2010.08.008
Finegold, Ira ; Dockhorn, Robert J. ; Ein, Daniel ; Dolen, William K. ; Oppenheimer, John ; Potter, Lawrence H. / Immunotherapy throughout the decades : From Noon to now. In: Annals of Allergy, Asthma and Immunology. 2010 ; Vol. 105, No. 5. pp. 328-336.
@article{19ef5b5f7e444c0da5f13b67193fe058,
title = "Immunotherapy throughout the decades: From Noon to now",
abstract = "Objective To review major milestones in the development of subcutaneous allergen immunotherapy in 20-year segments. Data Sources Review of the literature available in textbooks and journals. Study Selection Articles and books addressing major achievements in the development of subcutaneous allergy immunotherapy were selected for inclusion in this review. Results Immunotherapy administration has improved the lives of possibly millions of patients with hay fever. Asthmatic symptoms have been relieved if not ablated in millions as well. Insect venom hypersensitivity became treatable and highly effective. In the beginning years of immunotherapy, it was clear that immunotherapy worked; in the later years, the mechanisms for this efficacy were discovered. In this case, the therapy preceded its validation. Methods, materials, and safety have vastly improved. Postulated mechanisms explain much but not everything. Conclusions There is still research to be accomplished, improvements to be made, and, of course, patients to be made well.",
author = "Ira Finegold and Dockhorn, {Robert J.} and Daniel Ein and Dolen, {William K.} and John Oppenheimer and Potter, {Lawrence H.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1016/j.anai.2010.08.008",
language = "English (US)",
volume = "105",
pages = "328--336",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "5",

}

TY - JOUR

T1 - Immunotherapy throughout the decades

T2 - From Noon to now

AU - Finegold, Ira

AU - Dockhorn, Robert J.

AU - Ein, Daniel

AU - Dolen, William K.

AU - Oppenheimer, John

AU - Potter, Lawrence H.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Objective To review major milestones in the development of subcutaneous allergen immunotherapy in 20-year segments. Data Sources Review of the literature available in textbooks and journals. Study Selection Articles and books addressing major achievements in the development of subcutaneous allergy immunotherapy were selected for inclusion in this review. Results Immunotherapy administration has improved the lives of possibly millions of patients with hay fever. Asthmatic symptoms have been relieved if not ablated in millions as well. Insect venom hypersensitivity became treatable and highly effective. In the beginning years of immunotherapy, it was clear that immunotherapy worked; in the later years, the mechanisms for this efficacy were discovered. In this case, the therapy preceded its validation. Methods, materials, and safety have vastly improved. Postulated mechanisms explain much but not everything. Conclusions There is still research to be accomplished, improvements to be made, and, of course, patients to be made well.

AB - Objective To review major milestones in the development of subcutaneous allergen immunotherapy in 20-year segments. Data Sources Review of the literature available in textbooks and journals. Study Selection Articles and books addressing major achievements in the development of subcutaneous allergy immunotherapy were selected for inclusion in this review. Results Immunotherapy administration has improved the lives of possibly millions of patients with hay fever. Asthmatic symptoms have been relieved if not ablated in millions as well. Insect venom hypersensitivity became treatable and highly effective. In the beginning years of immunotherapy, it was clear that immunotherapy worked; in the later years, the mechanisms for this efficacy were discovered. In this case, the therapy preceded its validation. Methods, materials, and safety have vastly improved. Postulated mechanisms explain much but not everything. Conclusions There is still research to be accomplished, improvements to be made, and, of course, patients to be made well.

UR - http://www.scopus.com/inward/record.url?scp=78049469966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049469966&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2010.08.008

DO - 10.1016/j.anai.2010.08.008

M3 - Review article

C2 - 21055658

AN - SCOPUS:78049469966

VL - 105

SP - 328

EP - 336

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 5

ER -